The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog is intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Top topics on The CAM Report

    *Animal-assisted Therapy
    *Birth Defects
    *Arsenic in modern medicine
    *Mindfulness and cognitive behavioral therapy
    *TENS/FNS/VNS

  • Recent Posts

  • Recent Comments

    • Common sense considerations

      The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

    • Support this site

      If you found the information here helpful, please consider supporting this site.If you found the information here helpful, please consider supporting this site.

    Review of nutraceuticals to prevent prostate cancer

    prostate-cancer-ribbonThe paucity of well-designed studies in patients makes it difficult to make specific recommendations, according to researchers at the University of Toronto, in Ontario.

    After reviewing the medical research, they came to several conclusions.

    • Vitamin E, selenium, vitamin D, green tea, soy, and lycopene have been studied.
    • Other potential nutraceuticals that lack human data, most notably pomegranate, might also have a preventative role.

    The bottom line?

    The authors concluded, “Most of the literature involving nutraceuticals in prostate cancer is epidemiological and retrospective.”

    In other words, it’s not possible to make firm treatment recommendations based on these types of study designs.

    Despite this, the authors believe that “many of these ‘natural’ compounds have therapeutic potential and anticipate future studies will consist of well-designed clinical trials assessing combinations of compounds concurrently.”

    Others have looked at the evidence and come to slightly more positive conclusions, here and here.

    12/10/09 19:38 JR

    Leave a Comment

    You must be logged in to post a comment.

    Register Login